The Latest Breaking News from Macrogenics

MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates

MacroGenics (NASDAQ:MGNX) Chief Executive Officer Eric Risser said the biotechnology company has strengthened its balance sheet through two recent transactions while preparing for a series of clinical updates across its oncology pipeline. Speaking during an informal discussion hosted by Stifel seni

MarketBeat · May 27

Hawkish Fed Comments Knock Stocks Lower

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -1.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.55%. Stocks on Thursday gave up an early advance and sold off, with the S&P...

Barchart · Apr 4, 2024

Stocks Slide in Today's Afternoon Trading Session

The S&P 500 Index ($SPX ) (SPY ) is down -0.78%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.81%. Stocks are lower this afternoon, after rallying in the morning. Rising oil prices are a...

Barchart · Apr 4, 2024

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022

Upgrades

Benzinga · May 5, 2022

6 Analysts Have This to Say About Macrogenics

Macrogenics (NASDAQ:MGNX) has observed the following analyst ratings within the last quarter:

Benzinga · May 4, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022

Upgrades

Benzinga · May 4, 2022

Macrogenics: Q1 Earnings Insights

Macrogenics (NASDAQ:MGNX) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Macrogenics missed estimated earnings by 25.58%, reporting an EPS of $-1.08 versus an estimate of $-0.86.

Benzinga · May 3, 2022

Macrogenics's Earnings Outlook

Macrogenics (NASDAQ:MGNX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Macrogenics will report an earnings per share (EPS) of $-0.86.

Benzinga · May 2, 2022

What 4 Analyst Ratings Have To Say About Macrogenics

Analysts have provided the following ratings for Macrogenics (NASDAQ:MGNX) within the last quarter:

Benzinga · Feb 28, 2022

Recap: Macrogenics Q4 Earnings

Macrogenics (NASDAQ:MGNX) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · Feb 24, 2022